AI assistant
Atlantic Lithium Limited — Director's Dealing 2024
Feb 14, 2024
10433_rns_2024-02-14_75e258d0-4579-4b96-a0ad-aa5356d2dba6.pdf
Director's Dealing
Open in viewerOpens in your device viewer
15 February 2024
Notices of Changes to Directors’ Interests
The Board of Atlan�c Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlan�c Lithium" or the "Company"), the African-focussed lithium explora�on and development company targe�ng to deliver Ghana's first lithium mine, provides no�ce of changes to directors’ interests in accordance with lis�ng rule 3.19A.2, and as agent for the following directors for the purposes of sec�on 205G of the Corpora�ons Act 2001 (Cth):
-
Keith Muller
-
Amanda Harsas
No�ces for each of the directors are atached to this announcement.
Authorised for release by Amanda Harsas, Finance Director and Company Secretary, Atlan�c Lithium Limited.
For any further informa�on, please contact:
Atlan�c Lithium Limited
Neil Herbert (Execu�ve Chairman)
Amanda Harsas (Finance Director and Company Secretary)
[www.atlan�clithium.com.au ]
IR@atlan�clithium.com.au
Tel: +61 2 8072 0640
==> picture [126 x 5] intentionally omitted <==
15 February 2024
==> picture [90 x 21] intentionally omitted <==
==> picture [114 x 33] intentionally omitted <==
SP Angel Corporate Finance LLP
Nominated Adviser Jeff Kea�ng Charlie Bouverat Tel: +44 (0)20 3470 0470
==> picture [69 x 44] intentionally omitted <==
Yellow Jersey PR Limited Charles Goodwin Bessie Elliot atlan�[email protected] Tel: +44 (0)20 3004 9512
==> picture [69 x 44] intentionally omitted <==
Canaccord Genuity Limited Financial Adviser: Raj Khatri (UK) / Duncan St John, Chris�an Calabrese (Australia)
Corporate Broking: James Asensio Tel: +44 (0) 20 7523 4500
Notes to Editors:
About Atlan�c Lithium
www.atlan�clithium.com.au
Atlan�c Lithium is an AIM and ASX-listed lithium company advancing a por�olio of lithium projects in Ghana and Côte d’Ivoire through to produc�on.
on track to become Ghana’s first lithium-producing mine.
year mine life, making it one of the top 10 largest spodumene concentrate mines in the world.
The Project, which was awarded a Mining Lease in October 2023, is being developed under a funding agreement with Piedmont Lithium Inc.
Atlan�c Lithium holds 509km[2] and 774km[2] of tenure across Ghana and Côte d'Ivoire respec�vely, comprising significantly under-explored, highly prospec�ve licences.
==> picture [524 x 5] intentionally omitted <==
No�ces of Changes to Directors’ Interests
Page 2 of 2
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: Atlantic Lithium Limited
ABN: 17 127 215 132
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Keith Muller |
|---|---|
| Date of last notice | 2 January 2024 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
N/A |
| Date of change | 14 February 2024 |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | 100,000 Ordinary Shares 2,000,000 Options exercise price £0.60 expiry on 29 November 2024 2,000,000 Options exercise price £0.70 expiry on 29 November 2024 2,000,000 Options exercise price £0.50 expiry on 16 May 2025 653,160 Performance Rights with a vesting date 31 July 2025 816,450 Performance Rights with a vesting date 31 July 2026 |
|---|---|
| Class | Ordinary Shares |
| Number acquired | 100,000 |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
A$39,040 (£20,146) |
| No. of securities held after change | 200,000 Ordinary Shares 2,000,000 Options exercise price £0.60 expiry on 29 November 2024 2,000,000 Options exercise price £0.70 expiry on 29 November 2024 2,000,000 Options exercise price £0.50 expiry on 16 May 2025 653,160 Performance Rights with a vesting date 31 July 2025 816,450 Performance Rights with a vesting date 31 July 2026 |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Nature of change On-market trade Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| Interest after change | N/A |
Part 3 – +Closed period
| Part 3 – +Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 3
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: Atlantic Lithium Limited ABN: 17 127 215 132
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Amanda Harsas |
|---|---|
| Date of last notice | 2 January 2024 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Securities registered in the name of Birubi Grove Pty Ltd as trustee for the Harsas Family Trust |
| Date of change | 13 February 2024 |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | 4,400,000 Ordinary Shares 2,000,000 Options exercise price £0.60 expiry on 31 March 2025 3,000,000 Options exercise price £0.70 expiry on 23 April 2024 3,000,000 Options exercise price £0.75 expiry on 23 April 2024 2,000,000 Options exercise price £0.80 expiry on 23 April 2024 687,537 Performance Rights with a vesting date 31 July 2024 687,537 Performance Rights with a vesting date 31 July 2025 756,290 Performance Rights with a vesting date 31 July 2026 |
|---|---|
| Class | Ordinary Shares |
| Number acquired | 100,000 |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
A$37,000 (£19,091) |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 4,500,000 Ordinary Shares 2,000,000 Options exercise price £0.60 expiry on 31 March 2025 3,000,000 Options exercise price £0.70 expiry on 23 April 2024 3,000,000 Options exercise price £0.75 expiry on 23 April 2024 2,000,000 Options exercise price £0.80 expiry on 23 April 2024 687,537 Performance Rights with a vesting date 31 July 2024 687,537 Performance Rights with a vesting date 31 July 2025 756,290 Performance Rights with a vesting date 31 July 2026 |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
On-market trade |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 3
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
==> picture [456 x 182] intentionally omitted <==
----- Start of picture text -----
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A
----- End of picture text -----
Part 3 – +Closed period
Were the interests in the securities or contracts detailed above No traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to N/A proceed during this period? If prior written clearance was provided, on what date was this N/A provided?
- See chapter 19 for defined terms.
Appendix 3Y Page 4
01/01/2011